AAAAAA

   
Results: 1-17 |
Results: 17
HIGH-DOSE THERAPY FOR DIFFUSE LARGE-CELL LYMPHOMA IN FIRST REMISSION
Authors: PERRY AR GOLDSTONE AH
Citation: Ar. Perry et Ah. Goldstone, HIGH-DOSE THERAPY FOR DIFFUSE LARGE-CELL LYMPHOMA IN FIRST REMISSION, Annals of oncology, 9, 1998, pp. 9-14
BACKUP BONE-MARROW IS FREQUENTLY INEFFECTIVE IN PATIENTS WITH POOR PERIPHERAL-BLOOD STEM-CELL MOBILIZATION
Authors: WATTS MJ SULLIVAN AM LEVERETT D PENIKET AJ PERRY AR WILLIAMS CD DEVEREUX S GOLDSTONE AH LINCH DC
Citation: Mj. Watts et al., BACKUP BONE-MARROW IS FREQUENTLY INEFFECTIVE IN PATIENTS WITH POOR PERIPHERAL-BLOOD STEM-CELL MOBILIZATION, Journal of clinical oncology, 16(4), 1998, pp. 1554-1560
A CASE OF EBV-ASSOCIATED LYMPHOPROLIFERATIVE DISEASE FOLLOWING HIGH-DOSE THERAPY AND CD34-PURIFIED AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION
Authors: PENIKET AJ PERRY AR WILLIAMS CD MACMILLAN A WATTS MJ ISAACSON PG GOLDSTONE AH LINCH DC
Citation: Aj. Peniket et al., A CASE OF EBV-ASSOCIATED LYMPHOPROLIFERATIVE DISEASE FOLLOWING HIGH-DOSE THERAPY AND CD34-PURIFIED AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION, Bone marrow transplantation, 22(3), 1998, pp. 307-309
PROGENITOR-CELL YIELDS ARE FREQUENTLY POOR IN PATIENTS WITH HISTOLOGICALLY INDOLENT LYMPHOMAS ESPECIALLY WHEN MOBILIZED WITHIN 6 MONTHS OF PREVIOUS CHEMOTHERAPY
Authors: PERRY AR WATTS MJ PENIKET AJ GOLDSTONE AH LINCH DC
Citation: Ar. Perry et al., PROGENITOR-CELL YIELDS ARE FREQUENTLY POOR IN PATIENTS WITH HISTOLOGICALLY INDOLENT LYMPHOMAS ESPECIALLY WHEN MOBILIZED WITHIN 6 MONTHS OF PREVIOUS CHEMOTHERAPY, Bone marrow transplantation, 21(12), 1998, pp. 1201-1205
A SUCCESSFUL RE-INDUCTION IMMUNOTHERAPY REGIMEN FOR ACUTE-LEUKEMIA RELAPSING AFTER SIBLING ALLOGRAFT/
Authors: PERRY AR PENIKET AJ WATTS MJ INGS SJ GOLDSTONE AH MACKINNON S
Citation: Ar. Perry et al., A SUCCESSFUL RE-INDUCTION IMMUNOTHERAPY REGIMEN FOR ACUTE-LEUKEMIA RELAPSING AFTER SIBLING ALLOGRAFT/, Bone marrow transplantation, 21, 1998, pp. 246-246
TREATMENT WITH CAMPATH 1G LEADS TO EMERGENCE OF AN OCCULT PNH CLONE
Authors: MARKS AJ PERRY AR KOTTARIDIS PD PENIKET AJ HALE G WALDMANN H PATTERSON K RICHARDS S MACKINNON S
Citation: Aj. Marks et al., TREATMENT WITH CAMPATH 1G LEADS TO EMERGENCE OF AN OCCULT PNH CLONE, Bone marrow transplantation, 21, 1998, pp. 344-344
EVALUATION OF CLINICAL-SCALE CD34(- EXPERIENCE OF 71 IMMUNOAFFINITY COLUMN PROCEDURES() CELL PURIFICATION )
Authors: WATTS MJ SULLIVAN AM INGS SJ LEVERETT D PENIKET AJ PERRY AR WILLIAMS CD DEVEREUX S GOLDSTONE AH LINCH DC
Citation: Mj. Watts et al., EVALUATION OF CLINICAL-SCALE CD34(- EXPERIENCE OF 71 IMMUNOAFFINITY COLUMN PROCEDURES() CELL PURIFICATION ), Bone marrow transplantation, 20(2), 1997, pp. 157-162
THE LENGTH OF THE FIRST COMPLETE REMISSION (1-6 MONTHS, 7-12 MONTHS GREATER-THAN-12 MONTHS) DOES NOT PREDICT OUTCOME FOLLOWING BEAM AND AUTOTRANSPLANTATION FOR HODGKINS-DISEASE IN FIRST RELAPSE
Authors: KOTTARIDIS PD PENIKET AJ PERRY AR HARRISON CN DEELVIRA MCR MACMILLAN A DEVEREUX S LINCH DC GOLDSTONE AH
Citation: Pd. Kottaridis et al., THE LENGTH OF THE FIRST COMPLETE REMISSION (1-6 MONTHS, 7-12 MONTHS GREATER-THAN-12 MONTHS) DOES NOT PREDICT OUTCOME FOLLOWING BEAM AND AUTOTRANSPLANTATION FOR HODGKINS-DISEASE IN FIRST RELAPSE, Blood, 90(10), 1997, pp. 496-496
OUTCOME OF BEAM AUTOTRANSPLANTATION IN PATIENTS WITH HODGKINS-DISEASEPROGRESSING ON FIRST LINE THERAPY IS THE SAME AS IN PATIENTS TRANSPLANTED IN FIRST PARTIAL REMISSION
Authors: PENIKET AJ KOTTARIDIS PD PERRY AR DEELVIRA MCR DEVEREUX S MACMILLAN A GOLDSTONE AH LINCH DC
Citation: Aj. Peniket et al., OUTCOME OF BEAM AUTOTRANSPLANTATION IN PATIENTS WITH HODGKINS-DISEASEPROGRESSING ON FIRST LINE THERAPY IS THE SAME AS IN PATIENTS TRANSPLANTED IN FIRST PARTIAL REMISSION, Blood, 90(10), 1997, pp. 497-497
WHICH PBPC PATIENTS MAY BENEFIT FROM ACCELERATED PLATELET RECOVERY - FACTORS AFFECTING HOSPITAL DISCHARGE IN 152 CONSECUTIVE PATIENTS, THE RELEVANCE OF CD34 DOSE AND THE POTENTIAL IMPLICATIONS OF MEGAKARYOCYTEGROWTH-FACTOR
Authors: PENIKET AJ PERRY AR LEVERETT D WATTS M SULLIVAN A LINCH DC GOLDSTONE AH
Citation: Aj. Peniket et al., WHICH PBPC PATIENTS MAY BENEFIT FROM ACCELERATED PLATELET RECOVERY - FACTORS AFFECTING HOSPITAL DISCHARGE IN 152 CONSECUTIVE PATIENTS, THE RELEVANCE OF CD34 DOSE AND THE POTENTIAL IMPLICATIONS OF MEGAKARYOCYTEGROWTH-FACTOR, Blood, 90(10), 1997, pp. 1701-1701
PREEMPTIVE ANTI-CMV THERAPY DURING ALLOGENEIC BONE-MARROW TRANSPLANTATION BASED UPON BLOOD PCR SURVEILLANCE PRODUCES MOLECULAR EVIDENCE OF EFFECTIVE VIRAL CLEARANCE WITH ABSENCE OF CLINICALLY DETECTABLE DISEASE
Authors: PENIKET AJ HOWARD MR PREISER W PERRY AR KOTTARIDIS PD MCKEAG N BRINK NS MACKINNON S GOLDSTONE AH
Citation: Aj. Peniket et al., PREEMPTIVE ANTI-CMV THERAPY DURING ALLOGENEIC BONE-MARROW TRANSPLANTATION BASED UPON BLOOD PCR SURVEILLANCE PRODUCES MOLECULAR EVIDENCE OF EFFECTIVE VIRAL CLEARANCE WITH ABSENCE OF CLINICALLY DETECTABLE DISEASE, Blood, 90(10), 1997, pp. 2423-2423
ACQUIRED SIDEROBLASTIC ANEMIA INDUCED BY A COPPER-CHELATING AGENT
Authors: PERRY AR PAGLIUCA A FITZSIMONS EJ MUFTI GJ WILLIAMS R
Citation: Ar. Perry et al., ACQUIRED SIDEROBLASTIC ANEMIA INDUCED BY A COPPER-CHELATING AGENT, International journal of hematology, 64(1), 1996, pp. 69-72
THE HISTORY OF BONE-MARROW TRANSPLANTATION
Authors: PERRY AR LINCH DC
Citation: Ar. Perry et Dc. Linch, THE HISTORY OF BONE-MARROW TRANSPLANTATION, Blood reviews, 10(4), 1996, pp. 215-219
ADOPTIVE IMMUNOTHERAPY POST BONE-MARROW TRANSPLANTATION
Authors: PERRY AR MACKINNON S
Citation: Ar. Perry et S. Mackinnon, ADOPTIVE IMMUNOTHERAPY POST BONE-MARROW TRANSPLANTATION, Blood reviews, 10(4), 1996, pp. 237-241
A COMPARISON OF ESHAP-CSF VS CYCLOPHOSPHAMIDE 1.5G(G)M(2)+G-CSF FOR PBSC MOBILIZATION IN PRETREATED LYMPHOMA PATIENTS - A MATCHED-PAIR ANALYSIS/
Authors: WATTS MJ LEVERETT D SULLIVAN AM PENIKET AJ PERRY AR MACMILLAN A GOLDSTONE AH LINCH DC
Citation: Mj. Watts et al., A COMPARISON OF ESHAP-CSF VS CYCLOPHOSPHAMIDE 1.5G(G)M(2)+G-CSF FOR PBSC MOBILIZATION IN PRETREATED LYMPHOMA PATIENTS - A MATCHED-PAIR ANALYSIS/, Blood, 88(10), 1996, pp. 1571-1571
CHARACTERIZATION OF THE MAGNETIC DISSIPATION MECHANISM IN A SAMPLE USING INTERMODULATED DETECTION SUSCEPTOMETRY
Authors: PERRY AR SIMMONDS MB
Citation: Ar. Perry et Mb. Simmonds, CHARACTERIZATION OF THE MAGNETIC DISSIPATION MECHANISM IN A SAMPLE USING INTERMODULATED DETECTION SUSCEPTOMETRY, Physica. B, Condensed matter, 194, 1994, pp. 243-244
COMPLICATIONS OF PHARYNGEAL MYOTOMY FOR ALARYNGEAL VOICE REHABILITATION
Authors: SCOTT PMJ BLEACH NR PERRY AR CHEESMAN AD
Citation: Pmj. Scott et al., COMPLICATIONS OF PHARYNGEAL MYOTOMY FOR ALARYNGEAL VOICE REHABILITATION, Journal of Laryngology and Otology, 107(5), 1993, pp. 430-433
Risultati: 1-17 |